Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

  • Price (EUR)79.50
  • Today's Change-1.00 / -1.24%
  • Shares traded0.00
  • 1 Year change+45.87%
  • Beta--
Data delayed at least 15 minutes, as of Sep 30 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It is focused on acquiring and developing behavioral healthcare facilities. It is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States and Puerto Rico. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and direct care staff. Its specialty treatment facilities include residential recovery facilities, eating disorder facilities and comprehensive treatment centers.

  • Revenue in USD (TTM)2.45bn
  • Net income in USD277.32m
  • Incorporated2005
  • Employees15.90k
  • Location
    Acadia Healthcare Company IncSUITE 610, 830 CRESCENT CENTRE DRIVEFRANKLIN 37067United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ACHC:NSQ since
Centerpointe Behavioral Health SystemDeal completed03 Jan 202203 Jan 2022Deal completed28.80%--
Data delayed at least 15 minutes, as of Sep 30 2022 21:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.